[PDF][PDF] The genetic landscape and epidemiology of phenylketonuria

…, S Scholl-Bürgi, N Spécola, M Stojiljković… - The American Journal of …, 2020 - cell.com
Phenylketonuria (PKU), caused by variants in the phenylalanine hydroxylase (PAH) gene,
is the most common autosomal-recessive Mendelian phenotype of amino acid metabolism. …

A call for global action for rare diseases in Africa

…, J Chipeta, D Gavhed, A Larsson, M Stojiljkovic… - Nature …, 2020 - nature.com
The 11 th International Conference on Rare Diseases and Orphan Drugs (ICORD), South
Africa, included the Africa-Rare initiative launch and facilitated multi-stakeholder engagement …

Functional prediction and comparative population analysis of variants in genes for proteases and innate immunity related to SARS-CoV-2 infection

…, N Kotur, V Gasic, S Pavlovic, M Stojiljkovic - Infection, Genetics and …, 2020 - Elsevier
New coronavirus SARS-CoV-2 is capable to infect humans and cause a novel disease
COVID-19. Aiming to understand a host genetic component of COVID-19, we focused on variants …

[HTML][HTML] Can untreated PKU patients escape from intellectual disability? A systematic review

…, F Rutsch, A Setoodeh, M Stojiljkovic… - Orphanet journal of rare …, 2018 - Springer
Background Phenylketonuria (PKU) is often considered as the classical example of a genetic
disorder in which severe symptoms can nowadays successfully be prevented by early …

[HTML][HTML] Systematic documentation and analysis of human genetic variation in hemoglobinopathies using the microattribution approach

…, C Riemer, S Satta, I Schrijver, M Stojiljkovic… - Nature …, 2011 - nature.com
We developed a series of interrelated locus-specific databases to store all published and
unpublished genetic variation related to hemoglobinopathies and thalassemia and …

[HTML][HTML] A European spectrum of pharmacogenomic biomarkers: implications for clinical pharmacogenomics

…, S Pavlovic, G Saglio, J Setric, M Stojiljkovic… - PloS one, 2016 - journals.plos.org
Pharmacogenomics aims to correlate inter-individual differences of drug efficacy and/or toxicity
with the underlying genetic composition, particularly in genes encoding for protein factors …

Intra‐articular injection of autologous adipose‐derived mesenchymal stem cells in the treatment of knee osteoarthritis

…, Z Baščarević, M Stojiljković… - The journal of gene …, 2018 - Wiley Online Library
Background Osteoarthritis (OA) is a chronic degenerative joint disease and is considered to
be the fourth leading cause of disability and the second cause of inability to work in men. …

Newborn screening in southeastern Europe

…, V Sarnavka, A Savov, M Stojiljkovic… - Molecular genetics and …, 2014 - Elsevier
The aim of our study was to assess the current state of newborn screening (NBS) in the
region of southeastern Europe, as an example of a developing region, focusing also on future …

[HTML][HTML] Phenylketonuria screening and management in southeastern Europe–survey results from 11 countries

…, V Sarnavka, A Savov, M Stojiljkovic… - Orphanet journal of rare …, 2015 - Springer
Background We aimed to assess the current state of PKU screening and management in
the region of southeastern Europe. Methods A survey was performed involving all identified …

[HTML][HTML] Molecular biomarkers in Perthes disease: A review

…, G Nikčević, Z Baščarević, M Stojiljković… - Diagnostics, 2023 - mdpi.com
Background: Perthes disease is a juvenile form of osteonecrosis of the femoral head that
affects children under the age of 15. One hundred years after its discovery, some light has been …